Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05381402
What this trial is testing

Impact of COVID 19 on Psoriasis Patients

Who this might be right for
The Impact of COVID19 on Psoriasis Patients
Cairo University 230
Not applicableStudy completedNCT01282372
What this trial is testing

Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
AbbVie (prior sponsor, Abbott) 500
Post-approval studies (Phase 4)Study completedNCT01181570
What this trial is testing

Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

Who this might be right for
PsoriasisSleep Apnea, Obstructive
Innovaderm Research Inc. 20
Early research (Phase 1)Study completedNCT01297166
What this trial is testing

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 25
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Post-approval studies (Phase 4)Study completedNCT01876875
What this trial is testing

N-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

Who this might be right for
Plaque-type PsoriasisObesity (Body Mass Index >30 kg/m2)
Federico II University 44
Not applicableStudy completedNCT03865030
What this trial is testing

The Inner Ear Function in Psoriatic Patients

Who this might be right for
Psoriasis
HaEmek Medical Center, Israel 63
Not applicableStudy completedNCT03336281
What this trial is testing

Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

Who this might be right for
Psoriatic Arthritis
Janssen Cilag S.A.S. 221
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Not applicableLooking for participantsNCT03248284
What this trial is testing

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Who this might be right for
Psoriatic ArthritisEnthesitis
Odense University Hospital 30
Not applicableStudy completedNCT05065762
What this trial is testing

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Who this might be right for
Psoriasis
Bristol-Myers Squibb 232
Post-approval studies (Phase 4)Study completedNCT03942042
What this trial is testing

Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Not applicableActive Not RecruitingNCT06905028
What this trial is testing

Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)

Who this might be right for
Psoriasis ArthritisPsoriasis (PsO)
Charite University, Berlin, Germany 30
Large-scale testing (Phase 3)Study completedNCT04728360
What this trial is testing

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 556
Not applicableStudy completedNCT03757013
What this trial is testing

Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

Who this might be right for
Psoriasis
Amgen 453
Large-scale testing (Phase 3)Study completedNCT01445886
What this trial is testing

Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis

Who this might be right for
Nail Psoriasis
Yin-ku Lin 33
Not applicableUnknownNCT06176586
What this trial is testing

Mat Pilates Exercise Program in Patients With Axial Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Izmir Katip Celebi University 48
Early research (Phase 1)Ended earlyNCT00787137
What this trial is testing

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
PanGenetics UK Limited 17
Next Page